Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

30.51 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,587
Open 30.51
Bid (Size) 30.66 (100)
Ask (Size) 30.86 (300)
Prev. Close 30.51
Today's Range 30.51 - 30.51
52wk Range 25.77 - 43.15
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prediction: This Stock Could Double Over the Next 5 Years ↗
The obesity drug market is so large that only a small market share could lead to substantive price appreciation for the stock. 
Via The Motley Fool
News headline image
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
Could this be what Novo needs to turn things around? 
Via The Motley Fool
Topics Initial Public Offering

Performance

YTD
-13.9%
-13.9%
1 Month
-9.4%
-9.4%
3 Month
-18.5%
-18.5%
6 Month
-12.3%
-12.3%
1 Year
+11.5%
+11.5%

More News

Read More
News headline image
Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock. ↗
Via The Motley Fool
News headline image
3 Emerging Biotech Stocks With Significant Upside Potential ↗
Via MarketBeat
Topics Intellectual Property
News headline image
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why. ↗
Via The Motley Fool
News headline image
3 Non-AI Growth Stocks That Have Massive Upside ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? ↗
Via The Motley Fool
News headline image
Viking Therapeutics (VKTX) Delivers Great VK2735 Results: Here's a Word of Caution ↗
Via The Motley Fool
News headline image
3 Numbers From Viking Therapeutics' Weight-Loss Drug Trial That Have Wall Street Buzzing ↗
Via The Motley Fool
News headline image
MarketBeat Week in Review – 09/21 - 09/25 ↗
Via MarketBeat
Topics Artificial Intelligence Bonds Economy
News headline image
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? ↗
Via The Motley Fool
News headline image
Here's Why Viking Therapeutics Shares Slumped Today ↗
Via The Motley Fool
News headline image
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
Via MarketBeat
News headline image
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
Via The Motley Fool
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Viking Therapeutics’ VK2735 Shows Strong Weight-Loss Retention With Monthly Dosing ↗
Via MarketBeat
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic. ↗
Via The Motley Fool
News headline image
Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss ↗
Via MarketBeat
News headline image
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗
Via The Motley Fool
News headline image
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Analysts Have a $92 Target on Viking Therapeutics. Here's What Has to Go Right to Get There. ↗
Via The Motley Fool
News headline image
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. ↗
Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 30.51
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.04B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.